Synapse - Works

Results (988)

Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone

Journal Article

Lebovic, D.; Hoffman, J.; Levine, B. M.; Hassoun, H.; Landau, H.; Goldsmith, Y.; Maurer, M. S.; Steingart, R. M.; Cohen, A. D.; Comenzo, R. L.
British Journal of Haematology (2008)

Fulltext@MSK | Save

High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease

Journal Article

Hassoun, H.; Flombaum, C.; D'Agati, V. D.; Rafferty, B. T.; Cohen, A.; Klimek, V. M.; Boruchov, A.; Kewalramani, T.; Reich, L.; Nimer, S. D.; more...
Bone Marrow Transplantation (2008)

Fulltext@MSK | Save

High dose chemotherapy and autologous stem cell transplantation with melphalan in patients with monoclonal immunoglobulin deposition disease associated with multiple myeloma

Meeting Abstract

Hassoun, H.; Rafferty, B. T.; Flombaum, C.; D'Agati, V. D.; Klimek, V. M.; Cohen, A.; Boruchov, A.; Kewalramani, T.; Reich, L.; Landau, H.; more...
Blood (2007)

Fulltext@MSK | Save

Predictors of survival in de novo cardiac amyloidosis

Meeting Abstract

Comenzo, R. L.; Maurer, M.; Cohen, A.; Hassoun, H.; Zhou, P.; Lu, P.; Fleisher, M.; Lebovic, D.; Feldstein, J.; Steingart, R.; more...
Blood (2007)

Fulltext@MSK | Save

Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone ± thalidomide for systemic light-chain amyloidosis: Results of a phase II trial

Journal Article

Cohen, A. D.; Zhou, P.; Chou, J.; Teruya-Feldstein, J.; Reich, L.; Hassoun, H.; Levine, B.; Filippa, D. A.; Riedel, E.; Kewalramani, T.; more...
British Journal of Haematology (2007)

Fulltext@MSK | Save

Mobilization of blood stem cells with G-CSF in systemic light-chain amyloidosis: Dominant organ involvement significantly affects stem cell collection

Meeting Abstract

Comenzo, R.; Hassoun, H.; Reich, L.; Collins, N.; Nuta, A.; Chen, X. S.; Zhou, P.; Clark, B.; Teruya-Feldstein, J.; Fleisher, M.; more...
Blood (2006)

Fulltext@MSK | Save

Risk-adapted melphalan (MEL) with stem cell transplant (SCT) and adjuvant dexamethasone (D)+/- thalidomide (T) for AL patients achieves low treatment-related mortality (TRM) and high hematologic response rates

Meeting Abstract

Cohen, A. D.; Zhou, P.; Reich, L.; Hassoun, H.; Teruya-Feldstein, J.; Filippa, D. A.; Clark, B.; Stubblefield, M.; Fleisher, M.; Nimer, S. D.; more...
Amyloid (2006)

Fulltext@MSK | Save

Accuracy of the abdominal fat pad aspirate and ancillary test results in a patient population with a high prevalence rate of amyloidosis

Meeting Abstract

Clark, B.; Lin, O.; Moreira, A.; Teruya-Feldstein, J.; Antonescu, C.; Hassoun, H.; Zhou, P.; Fleisher, M.; Comenzo, R.
Amyloid (2006)

Fulltext@MSK | Save

Single-agent bortezomib in previously untreated multiple myeloma (MM): Results of a phase II multicenter study

Meeting Abstract

Anderson, K.; Richardson, P.; Chanan-Khan, A.; Schlossman, R.; Munshi, N.; Oaklander, A.; Heffner, L.; Hassoun, H.; Avigan, D.; Amato, A.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: Therapeutic implications

Journal Article

Chang, D. H.; Liu, N.; Klimek, V.; Hassoun, H.; Mazumder, A.; Nimer, S. D.; Jagannath, S.; Dhodapkar, M. V.
Blood (2006)

Fulltext@MSK | Save